All In Biotech

Drug Trial Radar · NCT00236639

A Study on Efficacy and Safety of Topiramate in the Treatment of Patients With Obesity

A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel Group, Dose-Response Study to Assess the Efficacy and Safety of Topiramate in the Treatment of Patients With Obesity

Last checked: Nov 19, 2026Latest source record: Apr 28, 2010 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 1,293 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,293

Actual

Start

Jul 2000

Primary completion

Not stated

Study completion Jun 2002

Sponsor

Lead sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Johnson & Johnson (Janssen) (JNJ)
Sponsor type
Industry
First posted
Oct 12, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to compare the efficacy and safety of topiramate (96, 192, and 256mg daily) with placebo in long-term treatment of obesity.

Conditions

  • Obesity

Interventions

  • topiramateDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The percent change in body weight from the baseline (randomization) to Week 60 (after one year of maintenance therapy).

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.